5-ketohexanoic acid oxime(75790-49-7)
- Name: 5-ketohexanoic acid oxime
- Synonyms:Caproicacid, d-oxo-, oxime (4CI); Hexanoicacid, 5-oxo-, oxime (6CI)
- Molecular Formula:C6H11 N O3
- Molecular Weight:145.158
- CAS Registry Number:75790-49-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.75790-49-7 5-ketohexanoic acid oxime
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.75790-49-7 5-ketohexanoic acid oxime
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.75790-49-7 5-ketohexanoic acid oxime
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:5-ketohexanoic acid oxime
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 66210-62-6/N-[2-chloro-5-[[4-(2,4-di-tert-pentylphenoxy)-1-oxobutyl]amino]phenyl]-alpha-(2,2-dimethyl-1-oxopropyl)-5-isopropyl-2-[(p-tolylsulphonyl)imino]-1,3,4-thiadiazol-3(2H)-acetamide
- 9075-24-5/Aspartylglucosylaminase
- 32065-99-9/3,4,5-Trimethoxybenzoic acid 4-(diethylamino)butyl ester
- 105919-39-9/1-[(2E)-3-(4-chlorophenyl)prop-2-enoyl]-2-methylpiperidine
- 204906-24-1/[3-{bis[3-(trifluoromethyl)phenyl]phosphanyl}-2-({bis[3-(trifluoromethyl)phenyl]phosphanyl}methyl)-2-methylpropyl]{bis[3-(trifluoromethyl)phenyl]}phosphane - rhodium (1:1)
- 6945-40-0/2-[(hydroxymethoxy)methyl]-5-methylphenol
- 13096-52-1/(6beta)-6,17-dihydroxy-3,11,20-trioxopregn-4-en-21-yl acetate
- 40283-63-4/Thiosulfuric acid hydrogen S-[2-(cyclooctylamino)-2-iminoethyl] ester
- 6230-87-1/7-chloro-4-[(2,4-dimethoxyphenyl)carbonyl]-5-(4-fluorophenyl)-1,3,4,5-tetrahydro-2H-1,4-benzodiazepin-2-one
- 133943-50-7/auranticin A
- 56291-42-0/7-(1,2-dimethylheptyl)-2,2,4,4-tetramethyl-1,4-dihydro-2H-thieno[2,3-c]chromen-9-ol
- 100853-40-5/Naphtho[2,3-b]furan-3-methanol,5,6,7,8-tetrahydro-9-hydroxy-4,5-dimethyl-, a-acetate, (5S)- (9CI)
- 57126-38-2/Lithsil S
- 20004-13-1/8-Oxa-3,5-dithia-4-stannahexadecanoic acid,4,4-dimethyl-7-oxo-,octyl ester
- 19019-23-9/5-bromo-2-(propan-2-yl)-1-benzofuran
- 3254-85-1/2-amino-4,7-dioxo-1,4,7,8-tetrahydropteridine-6-carboxylic acid
- 28274-57-9/METHANESELENINIC ACID
- 3073-04-9/1,1':3',1'':3'',1''':4''',1''''-Quinquephenyl
- 64046-83-9/N-cyclohexylacridin-9-amine
- 75790-49-7/5-ketohexanoic acid oxime
- 75627-09-7/â-D-Glucopyranoside,(3â,25R)-17-hydroxyspirost- 5-en-3-yl O-6-deoxy-R-L-mannopyranosyl-(1f2)-O- [6-deoxy-R-L-mannopyranosyl-(1f3)]-
- 156848-89-4/L-Leucinamide,N-[4-[(aminoiminomethyl)amino]-1-oxobutyl]-L-phenylalanyl-N-[(1S,2R)-1-(cyclohexylmethyl)-2-hydroxy-2-(2-thiazolyl)ethyl]-(9CI)
- 7271-94-5/Pyrimido[4,5-e]-1,2,4-triazine-6,8(5H,7H)-dione, 5,7-dimethyl-3-(methy lthio)-
- 70008-50-3/N-(diphosphonomethyl)-L-aspartic acid
- 93820-10-1/Hydrogen bis(4-((5-chloro-2-hydroxyphenyl)azo)-2-(2-chlorophenyl)-2,4-dihydro-5-methyl-3H-pyrazol-3-onato(2-))cobaltate(1-), compound with bis(2-ethylhexyl)amine (1:1)
- 55212-02-7/3-({[3-(trifluoromethyl)phenyl]amino}methyl)-2,3-dihydro-5H-1,4-benzodioxepin-5-one
- 77432-56-5/(7Z)-10-methyloxecane-2,7-dione 7-oxime
- 33893-89-9/4-(2H-TETRAZOL-5-YL)-PYRIDINE
- 127942-98-7/1,2-Ethanediol,1-[(3R,4aR,6aS,10aS)-2,4a,5,6,6a,7,8,9,10,10a-decahydro-3,4a,7,7,10a-pentamethyl-3H-naphtho[2,1-b]pyran-3-yl]-,(1R)-
- 59514-43-1/tetrabutylphosphonium 3,5-bis(methoxycarbonyl)benzenesulfonate